MARKET

AMPE

AMPE

AMPIO PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

1.825
+0.035
+1.96%
Opening 12:18 06/24 EDT
OPEN
1.810
PREV CLOSE
1.790
HIGH
1.840
LOW
1.810
VOLUME
408.92K
TURNOVER
--
52 WEEK HIGH
2.980
52 WEEK LOW
0.5312
MARKET CAP
357.13M
P/E (TTM)
-23.1893
1D
5D
1M
3M
1Y
5Y
BRIEF-Ampio Pharmaceuticals, Inc. To Join The Russell 2000® Index And Russell 3000® Index
reuters.com · 6d ago
Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index
PR Newswire - PRF · 6d ago
Ampio to Join Russell 2000, 3000 Indexes
MT Newswires · 6d ago
Ampio Pharmaceuticals Says New Data Shows Efficacy of Ampion in Patients With Severe Osteoarthritis of the Knee
MT Newswires · 06/17 15:31
Ampio highlights integrated data from Ampion osteoarthritis of the knee trials
Ampio Pharmaceuticals ([[AMPE]] +1.4%) posts newly integrated data from four of its earlier clinical trials utilizing the company's Ampion treatment for treating osteoarthritis of the knee ((OAK)).The pooled data showed a reduction
Seekingalpha · 06/17 13:58
BRIEF-Ampio Provides Update On Osteoarthritis Of The Knee (Oak) Program, Reiterates Compelling Data In Earlier Phase Iii Trials Of Ampion In Severe Oak
reuters.com · 06/17 13:17
Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program, Reiterates Compelling Data in Earlier Phase III Trials of Ampion in Severe OAK
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today reported newly integrated data from four of its earlier clinical trials with cons...
PR Newswire · 06/17 13:15
Thinking about buying stock in Eloxx Pharmaceuticals, Sio Gene Therapies, Ampio Pharmaceuticals, Applied Genetic Technologies, or Cyclo Therapeutics?
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ELOX, SIOX, AMPE, AGTC, and CYTH.
PR Newswire - PRF · 06/15 13:31
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMPE. Analyze the recent business situations of AMPIO PHARMA through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMPE stock price target is 4.500 with a high estimate of 5.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 82
Institutional Holdings: 20.94M
% Owned: 10.70%
Shares Outstanding: 195.69M
TypeInstitutionsShares
Increased
13
1.36M
New
15
8.35M
Decreased
18
7.05M
Sold Out
15
1.46M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.64%
Pharmaceuticals & Medical Research
+1.10%
Key Executives
Chairman/Chief Executive Officer/Director
Michael Macaluso
Chief Financial Officer/Treasurer/Secretary
Daniel Stokely
Chief Operating Officer
Holli Cherevka
Director
David Bar-Or
Independent Director
Philip Coelho
Independent Director
Richard Giles
Independent Director
David Stevens
No Data
About AMPE
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.

Webull offers kinds of Ampio Pharmaceuticals Inc stock information, including AMEX:AMPE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMPE stock methods without spending real money on the virtual paper trading platform.